Treatment with angiotensin II in COVID-19 patients may not be beneficial

Crit Care. 2020 Sep 4;24(1):546. doi: 10.1186/s13054-020-03233-6.

Susanne Rysz^{1

2}, Francesca Campoccia Jalde^{2

3}, Anders Oldner^{2

3}, Lars I Eriksson^{2

3}, Johan Lundberg^{4

5}, Malin Jonsson Fagerlund^{6

7}

¹ Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
² Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
³ Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
⁴ Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden.
⁶ Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden. malin.jonsson.fagerlund@ki.se.
⁷ Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. malin.jonsson.fagerlund@ki.se.

No abstract available

Publication types